Displaying 11-20 of 22 results for

The impact of COVID-19 has changed the way we conduct business, and now, more than ever, illuminates the need for manufacturers to assess their processes and implement smart manufacturing technology.

Stratasys Ltd., the 3D printing company, says its own customer base prompted it to become involved in responding to the novel coronavirus (COVID-19).

In the U.S., we are not seeing any specific localized disruption yet, although I’m watching New Jersey where it could be on the cusp. There are a lot of manufacturing facilities there in pharmaceuticals and chemicals, and therefore that’s an area I think we should be paying attention to.

Siemens connects healthcare providers and medical designers to produce components through additive manufacturing in wake of COVID-19 pandemic.

A panel of experts and startups in medical 3D printing provided insights into efforts to help the COVID-19 pandemic in a webinar organized by 3DHEALS

We can be proud of how companies have remained resilient throughout the pandemic. That resiliency will be further challenged.

Manufacturers are increasingly analyzing their supply chains to mitigate cybersecurity and environmental risks with the goal of building more secure, resilient, agile organizations, keynote panelists at the Best of SMX virtual event said in October.

In January, as the new coronavirus was rapidly spreading around the world, scientists at Moderna teamed up with the National Institutes of Health to pursue a potential vaccine based on an experimental genetic technology involving messenger RNA (mRNA), a molecule in every cell that helps translate DNA into biological functions.

Bioprinting is in the vanguard of the war against the novel coronavirus and holds promise for greater understanding of the way SAR-CoV-2 works in the human body.

Stratasys and Origin have signed an agreement in which Stratasys will market and promote Origin 3D-printed nasopharyngeal (NP) swabs to healthcare providers and other testing centers in the U.S.